From recent publications, it appeared that the germline CHEK2*1100delC mutation in fact confers low-penetrance susceptibility to breast cancer (Meijers-Heijboer et al, 2002; Vahteristo et al, 2002). This evidence concerns the gene CHEK2 and breast cancer.